Bulletin
Investor Alert

Merus N.V.

NAS: MRUS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208894347/composite

$

22.19

Change

0.00 0.00%

Volume

Volume 4,987

Jun 27, 2022, 4:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208894347/composite

Today's close

$ 22.08

$ 22.19

Change

+0.11 +0.50%

Day low

Day high

$21.64

$22.97

Open
Open: 21.99

52 week low

52 week high

$13.47

$33.09

Open

Market cap

$961.59M

Average volume

387,290

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrus

MarketWatch News on MRUS

  1. Merus started at outperform with $45 stock price target at BMO Capital

    2:51 p.m. Feb. 11, 2022

    - Tomi Kilgore

  2. Lilly signs cancer drug deal worth up to $1.6 billion

    8:35 a.m. Jan. 20, 2021

    - Jaimy Lee

  3. Johnson & Johnson Is Selling These 2 Biotech Stocks

    8:00 a.m. Jan. 25, 2019

    - Barron's Online

  4. 5 biotech buyout candidates you should look at right now

    2:10 p.m. Jan. 28, 2018

    - Jeff Reeves

  5. Merus N.V. stock price target lowered to $20 vs. $28 at RBC

    8:54 a.m. Jan. 2, 2018

    - Ciara Linnane

  6. Merus N.V. downgraded to sector perform vs. outperform at RBC

    8:54 a.m. Jan. 2, 2018

    - Ciara Linnane

  7. Charting the Market

    1:04 a.m. Dec. 24, 2016

    - Barron's Online

  8. Merus upgraded to buy from neutral at Citigroup

    1:18 p.m. Dec. 22, 2016

    - Tomi Kilgore

  9. Merus's stock soars 60% premarket after favorable rulings on European patent

    9:17 a.m. Dec. 21, 2016

    - Tomi Kilgore

  10. Merus downgraded to neutral from buy at Citigroup

    10:36 a.m. Nov. 7, 2016

    - Tomi Kilgore

  11. Merus started at outperform with $14 stock price target at Wedbush Securities

    7:16 a.m. June 13, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/mrus

Other News on MRUS

  1. AVDL, SIGA, PSHG and IOVA among mid-day movers

    12:56 p.m. May 27, 2022

    - Seeking Alpha

  2. Merus N.V. (MRUS) Investor Presentation - Slideshow

    3:05 p.m. May 24, 2022

    - Seeking Alpha

  3. 10-Q: MERUS N.V.

    4:12 p.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Tracking Baker Brothers Portfolio - Q4 2021 Update

    10:10 p.m. March 30, 2022

    - Seeking Alpha

  5. Incyte's (INCY) Going Gets Tough Due to Pipeline Setbacks

    9:10 a.m. March 18, 2022

    - Zacks.com

  6. 10-K: MERUS N.V.

    5:39 p.m. Feb. 28, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. Incyte withdraws NDA for lymphoma treatment parsaclisib

    5:51 p.m. Jan. 25, 2022

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/mrus

Press Releases on MRUS

  1. Merus to Participate in Upcoming Investor Conferences

    9:00 a.m. Feb. 3, 2022

    - GlobeNewswire

  2. Promising Developments in Breast Cancer Treatments Ahead in 2022

    11:58 a.m. Jan. 12, 2022

    - PR Newswire - PRF

  3. Promising Developments in Breast Cancer Treatments Ahead in 2022

    11:55 a.m. Jan. 12, 2022

    - Financial News Media

  4. Merus Announces Pricing of Public Offering of Common Shares

    9:02 p.m. Nov. 4, 2021

    - GlobeNewswire

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.